Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts
Tóm tắt
Từ khóa
Tài liệu tham khảo
Eklund, E.A. , Newell, J.W., Sun, L., Seo, N.S., Alper, G., Willert, J., and Freeze, H.H. (2005) Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. Mol. Genet. Metab., 84, 25–31.
Freeze, H.H. (2001) Update and perspectives on congenital disorders of glycosylation. Glycobiology, 11, 129R–143R.
Imbach, T. , Schenk, B., Schollen, E., Burda, P., Stutz, A., Grunewald, S., Bailie, N.M., King, M.D., Jaeken, J., Matthijs, G., and others. (2000) Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J. Clin. Invest., 105, 233–239.
Jaeken, J. (2003) Komrower lecture. Congenital disorders of glycosylation (CDG): it’s all in it! J. Inherit. Metab. Dis., 26, 99–118.
Kim, S. , Westphal, V., Srikrishna, G., Mehta, D.P., Peterson, S., Filiano, J., Karnes, P.S., Patterson, M.C., and Freeze, H.H. (2000) Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie). J. Clin. Invest., 105, 191–198.
Kjaergaard, S. , Kristiansson, B., Stibler, H., Freeze, H.H., Schwartz, M., Martinsson, T., and Skovby, F. (1998) Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A. Acta Paediatr., 87, 884–888.
Marquardt, T. and Denecke, J. (2003) Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur. J. Pediatr., 162, 359–379.
Mayatepek, E. and Kohlmüller, D. (1998) Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency. Eur. J. Pediatr., 157, 605–606.
Mayatepek, E. , Schroder, M., Kohlmuller, D., Bieger, W.P., and Nutzenadel, W. (1997) Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I. Acta Paediatr., 86, 1138–1140.
Muus, U. , Kranz, C., Marquardt, T., and Meier, C. (2004) Cyclosaligenyl-mannose-1-monophosphates as a new strategy in CDG-Ia therapy: hydrolysis, mechanistic insights and biological activity. Eur. J. Org. Chem., 2004, 1228–1235.
Niehues, R. , Hasilik, M., Alton, G., Korner, C., Schiebe-Sukumar, M., Koch, H.G., Zimmer, K.P., Wu, R., Harms, E., Reiter, K., and others. (1998) Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J. Clin. Invest., 101, 1414–1420.
Nishikawa, A. and Mizuno, S. (2001) The efficiency of N-linked glycosylation of bovine DNase I depends on the Asn-Xaa-Ser/Thr sequence and the tissue of origin. Biochem. J., 355, 245–248.
Panneerselvam, K. and Freeze, H.H. (1996) Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. J. Clin. Invest., 97, 1478–1487.
Rudolf, M.T. , Traynor-Kaplan, A.E., and Schultz, C. (1998) A membrane-permeant, bioactivatable derivative of Ins(1,3,4)P3 and its effect on Cl(-)-secretion from T84 cells. Bioorg. Med. Chem. Lett., 8, 1857–1860.
Rutschow, S. , Thiem, J., Kranz, C., and Marquardt, T. (2002) Membrane-permeant derivatives of mannose-1-phosphate. Bioorg. Med. Chem., 10, 4043–4049.
Sarkar, A.K. , Brown, J.R., and Esko, J.D. (2000) Synthesis and glycan priming activity of acetylated disaccharides. Carbohydr. Res., 329, 287–300.
Schultz, C. , Vajanaphanich, M., Harootunian, A.T., Sammak, P.J., Barrett, K.E., and Tsien, R.Y. (1993) Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP. J. Biol. Chem., 268, 6316–6322.